Certara, Inc. (CERT) fundamentals score
Certara is a global leader in biosimulation science, technology, and consulting services for using Model-Informed Drug Development (“MIDD”) in the global biopharmaceutical and biotech industry. MIDD is an approach that utilizes biological and statistical models derived from preclinical, clinical, and evidence data to inform decision-making in drug research and development, and commercialization.
Services-Prepackaged Software · Technology · Listed on NASDAQ
Overall: 5.3 out of 10, Mixed fundamentals
- Growth: 3.5/10
- Profitability: 3.3/10
- Financial health: 6.1/10
- Earnings quality: 9.1/10
- Valuation: 6.5/10
Scores are calculated from Certara, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Technology stocks
- Micron Technology, Inc. (MU): 9.0/10
- Broadcom Inc. (AVGO): 8.9/10
- Logitech International S.A. (LOGI): 8.8/10
- Applovin Corporation (APP): 8.7/10
- Cirrus Logic, Inc. (CRUS): 8.7/10
- Hamilton Beach Brands Holding Company (HBB): 8.7/10
- Nerdwallet, Inc. (NRDS): 8.7/10
- Sandisk Corporation (SNDK): 8.7/10